Tatva Chintan Pharma Chem Ltd. - Research Center
543321 TATVA Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 378.68 | 403.04 | 427.81 | 291.19 | 253.84 |
| Operating profit | 66.87 | 54.68 | 105.77 | 65.19 | 52.39 |
| Interest | 6.51 | 8.38 | 4.83 | 4.21 | 3.94 |
| Gross profit | 67.87 | 51.97 | 111.45 | 66.08 | 49.01 |
| EPS (Rs) | 12.55 | 18.26 | 43.31 | 25.57 | 43.51 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 7.51 | 5.68 | 10.51 | 5.10 | 0.56 |
| Stock adjustment | -10.72 | 6.51 | -58.04 | -5.20 | -16.03 |
| Raw material | 178.76 | 215.82 | 254.49 | 150.91 | 146.16 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 54.76 | 38.60 | 30.81 | 24.13 | 20.53 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 89.01 | 87.44 | 94.77 | 56.16 | 50.80 |
| Provisions made | - | - | - | - | - |
| Depreciation | 25.60 | 9.55 | 8.18 | 6.73 | 4.79 |
| Taxation | 12.92 | -1.63 | 7.28 | 7.99 | 9.25 |
| Net profit / loss | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 |
| Extra ordinary item | - | -3.59 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.39 | 22.17 | 22.17 | 20.09 | 8.04 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 17.66 | 13.57 | 24.72 | 22.39 | 20.64 |
| GPM (%) | 17.57 | 12.72 | 25.43 | 22.30 | 19.26 |
| NPM (%) | 7.60 | 9.90 | 21.90 | 17.33 | 13.74 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis